We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOCS
801
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$2.01M 0.01%
41,412
-140,082
-77% -$6.76M
CHNG
802
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$2M 0.01%
86,954
-215,143
-71% -$4.95M
CF icon
803
CF Industries
CF
$18.2B
$2M 0.01%
38,797
-107,306
-73% -$5.45M
KCAC.WS
804
CALL
DELISTED
Kensington Capital Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one
KCAC.WS
$1.99M 0.01%
+200,000
New +$376K
RMGB
805
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
$1.99M 0.01%
200,000
– –
ENJY
806
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$1.98M 0.01%
200,000
– –
BPMC
807
DELISTED
Blueprint Medicines
BPMC
$1.97M 0.01%
+22,413
New +$2.05M
EQD.WS
808
CALL
DELISTED
Equity Distribution Acquisition Corp. Warrants, each whole warrant exercisable for one share of Clas
EQD.WS
$1.97M 0.01%
200,000
– –
BBL
809
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$1.97M 0.01%
+33,032
New +$2.02M
MOLN
810
Molecular Partners
MOLN
$155M
$1.97M 0.01%
+96,499
New +$1.91M
SPH icon
811
Suburban Propane Partners
SPH
$1.17B
$1.96M 0.01%
+127,944
New +$1.92M
GSAQW
812
CALL
DELISTED
Global Synergy Acquisition Corp. Warrant
GSAQW
$1.96M 0.01%
201,681
– –
SUPN icon
813
Supernus Pharmaceuticals
SUPN
$2.76B
$1.94M 0.01%
+63,084
New +$1.93M
XLNX
814
DELISTED
Xilinx Inc
XLNX
$1.94M 0.01%
13,434
+11,138
+485% +$1.42M
GETR
815
DELISTED
Getaround, Inc.
GETR
$1.94M 0.01%
+200,000
New +$1.95M
TPR icon
816
Tapestry
TPR
$33B
$1.93M 0.01%
44,472
+9,303
+26% +$415K
DCRNW
817
CALL
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$1.93M 0.01%
+195,898
New +$239K
CYT
818
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1.93M 0.01%
+90,258
New +$1.69M
CAI
819
DELISTED
CAI International, Inc.
CAI
$1.93M 0.01%
34,403
-34,302
-50% -$1.52M
BXMT icon
820
Blackstone Mortgage Trust
BXMT
$2.37B
$1.92M 0.01%
+60,309
New +$1.94M
MT icon
821
ArcelorMittal
MT
$55.8B
$1.92M 0.01%
+61,909
New +$1.92M
CORZW
822
CALL
DELISTED
Core Scientific, Inc. Warrant
CORZW
$1.91M 0.01%
+193,750
New +$231K
CFMS
823
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.9M 0.01%
66,077
+14,956
+29% +$353K
TSCO icon
824
Tractor Supply
TSCO
$18.1B
$1.89M 0.01%
50,795
-109,835
-68% -$4.03M
HRMY icon
825
Harmony Biosciences
HRMY
$2.28B
$1.89M 0.01%
66,761
-22,186
-25% -$666K
31 32
33
34 35

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.